The child and adolescent first-episode psychosis study (CAFEPS): Design and baseline results

Schizophrenia Research

Volumn 91, Issue 1-3, 2007, Pages 226-237

  Castro Fornieles, Josefina ^a   Parellada, Mara ^b   Gonzalez Pinto, Ana ^c   Moreno, Dolores ^b   Graell, Montserrat ^d   Baeza, Immaculada ^a   Otero, Soraya ^e   Soutullo, Cesar A ^f   Crespo Facorro, Benedicto ^e   Ruiz Sancho, Ana ^b   Desco, Manuel ^b   Rojas Corrales, Olga ^g   Patiño, Ana ^f   Carrasco Marin, Eugenio ^e   Arango, Celso ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL TXAGORRITXU   (Spain)

^d HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^f Hospital of Santiago de Compostela   (Spain)

^g UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

Adolescents; Child onset; Children; Early onset; First episode psychoses

Indexed keywords

ADOLESCENT; ARTICLE; CHILD PSYCHIATRY; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISABILITY ASSESSMENT SCHEDULE; EARLY DIAGNOSIS; EDUCATION; FEMALE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOLOGICAL PARAMETERS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NEGATIVE SYNDROME; NEUROIMAGING; ONSET AGE; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SCHOOL CHILD; SCORING SYSTEM; SOCIAL STATUS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; BRAIN; CHILD; COGNITION DISORDERS; COMMUNICATION; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PARENT-CHILD RELATIONS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA; SOCIAL ADJUSTMENT; TIME FACTORS;

EID: 33847363905     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.12.004     Document Type: Article

References (69)

1. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., and Gorman J.M. Assessment of insight in psychosis. Am. J. Psychiatry 150 (1993) 873-879
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) (1994), American Psychiatric Association, Washington, D.C
3. Asarnow J.R., Tompson M.C., and McGrath E.P. Annotation: childhood-onset schizophrenia: clinical and treatment issues. J. Child Psychol. Psychiatry 45 (2004) 180-194
4. Ashburner J., and Friston K. Multimodal image coregistration and partitioning - a unified framework. Neuroimage 6 (1997) 209-217
5. Ballageer T., Malla A., Manchanda R., Takhar J., and Haricharan R. Is adolescent-onset first-episode psychosis different from adult onset?. J. Am. Acad. Child Adolesc. Psych. 44 (2005) 782-789
6. Barnes H., and Olson D.H. Parent-adolescent communication. In: Olson D.H., MCCubbin H.I., Barnes H., Larsen A., Muxen M., and Wilson M. (Eds). Family Inventories: Inventories Used in a National Survey of Families Across the Family Life Cycle. 2nd. Revised Edition (1992), University of Minnesota, St. Paul MN
7. Boogaart A. Removal of Water Resonance from 1H Magnetic Resonance Spectra (1994), Clarendon Press, Oxford
8. Brickman A.M., Buchsbaum M.S., Bloom R., Bokhoven P., Paul-Odouard R., Haznedar M.M., Dahlman K.L., Hazlett E.A., Aronowitz J., Heath D., and Shihabuddin L. Neuropsychological functioning in first-break, never-medicated adolescents with psychosis. J. Nerv. Ment. Dis. 192 (2004) 615-622
9. Brickman A.M., et al. Neuropsychological functioning in first-break, never-medicated adolescents with psychosis. J. Nerv. Ment. Dis. 192 9 (2004) 615-622
10. Buchanan R.W., and Heinrichs D.W. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 27 (1989) 335-350
11. Cannon-Spoor H.E., Potkin S.G., and Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 26 (1982) 351-366
12. Conners C.K. Conners' Continuous Performance Test-II, Computer Program for Windows. Technical Guide and Software Manual (2000), MHS Multi-Health Systems Inc.
13. Correll C.U., Lencz T., Smith C.W., Auther A.M., Nakayama E.Y., Hovey L., Lonsen R., Shah M., Foley C., and Cornblatt B.A. Prospective study of adolescents with subsyndromal psychosis: characteristics and outcome. J. Child Adolesc. Psychopharmacol. 15 (2005) 418-433
14. De la Peña F., Ulloa R., Higuera F., Ortiz S., Arechavaleta B., Foullux C., Nogales I., Marquez M., Cruz E., Martinez P., Hernandez L., and Domínguez E. Interrater reliability of the Spanish version of the K-SADS-PL. Am. Acad. Child Adolesc. Psychiatry, Annual Meeting, San Francisco, CA, 2002. Scientific Proceedings, NR Poster vol. A35 (2002) 96
15. Desco M., Pascau J., Reig S., Gispert J.D., Santos A., Benito B., Molina V., and Garcia-Barreno P. Multimodality Image Quantification Using Talairach Grid. Proc. SPIE Medical Imaging 4432 (2001) 1385-1392
16. Do K.Q., Trabesinger A.H., Kirsten-Kruger M., Lauer C.J., Dydak U., Hell D., Holsboer F., Boesiger P., and Cuenod M. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur. J. Neurosci. 12 (2000) 3721-3728
17. Endicott J., Spitzer R.L., Fleiss J.L., and Cohen J. The Global Assessment Scale. Arch. Gen. Psychiatry 33 (1976) 766-777
18. Ganguli R., Rabin B.S., Kelly R.H., Lyte M., and Ragu U. Clinical and laboratory evidence of autoimmunity in acute schizophrenia. Ann. N.Y. Acad. Sci. 496 (1987) 676-685
19. Goodman R. Psychometric properties of the Strengths and Difficulties Questionnaire. J. Am. Acad. Child Adolesc. Psych. 40 (2001) 337-1345
20. Guy W., and ECDEU. Assessment Manual for Psychopharmacology, Revised (1976), US Department of Health, Education and Welfare, Rockville, MD
21. Haim R., Rabinowitz J., and Bromet E. The relationship of premorbid functioning to illness course in schizophrenia and psychotic mood disorders during two years following first hospitalization. J. Nerv. Ment. Dis. 194 (2006) 791-795
22. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6 (1967) 278-296
23. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
24. Hollingshead A.B., and Redlich F.C. Social Class and Mental Illness (1958), Wiley, New York
25. Janca A., Kastrup M., Katschnig H., Lopez-Ibor Jr. J.J., and Mezzich J.E. The World Health Organization Short Disability Assessment Schedule (WHO DAS-S): a tool for the assessment of difficulties in selected areas of functioning of patients with mental disorders. Soc. Psychiatry Psychiatr. Epidemiol. 31 (1996) 349-359
26. Kates W.R., Warsofsky I.S., Patwardhan A., Abrams M.T., Liu A.M., Naidu S., Kaufmann W.E., and Reiss A.L. Automated Talairach atlas-based parcellation and measurement of cerebral lobes in children. Psychiatry Res. 91 (1999) 11-30
27. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., Williamson D., and Ryan N. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psych. 36 (1997) 980-988
28. Kay S.R., Fiszbein A., and Opler L.A. The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies. Psychol. Med. 27 (1987) 411-419
29. Kenny J.T., Friedman L., Findling R.L., Swales T.P., Strauss M.E., Jesberger J.A., and Schulz S.C. Cognitive impairment in adolescents with schizophrenia. Am. J. Psychiatry 154 (1997) 1613-1615
30. Kim Y.K., Myint A.M., Lee B.H., Han C.S., Lee H.J., Kim D.J., and Leonard B.E. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004) 1129-1134
31. Kravariti E., Morris R.G., Rabe-Hesketh S., Murray R.M., and Frangou S. The Maudsleyearly-onset schizophrenia study: cognitive function in adolescent-onset schizophrenia. Schizophr. Res. 65 (2003) 95-103
32. Kumra S., Wiggs E., Bedwell J., Smith A.K., Arling E., Albus K., Hamburger S.D., McKenna K., Jacobsen L.K., Rapoport J.L., and Asarnow R.F. Neuropsychological deficits in pediatric patients with childhood-onset schizophrenia and psychotic disorder not otherwise specified. Schizophr. Res. 42 (2000) 135-144
33. Kumra S., Nicholson R., and Rapaport J.L. Childhood-onset schizophrenia. Research update. In: Zipursky R.B., and Schulz S.C. (Eds). The Early Stages of Schizophrenia (2002), American Psychiatric Publishing, Inc., Washington, D.C
34. Lewis S.W., Owen M.J., and Murray R.M. Obstetric complications and schizophrenia: methodology and mechanisms. In: Schulz S.C., and Tamminga C.A. (Eds). Schizophrenia. A Scientific Focus (1989), Oxford University Press, New York
35. Lewis S.J., Zammit S., Gunnell D., and Smith G.D. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am. J. Med. Genet. B Neuropsychiatr. Genet. 135 (2005) 2-4
36. Lezak M.D. Neuropsychological Assessment. 3rd ed. (1995), Oxford University Press, New York
37. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., and Elgen K. UKU side effect rating scale. Acta Psychiatr. Scand. 76 Suppl. 334 (1987) 7s-100s
38. Mahadik S.P., and Mukherjee S. Free radical pathology and the antioxidant defense in schizophrenia. Schizophr. Res. 19 (1996) 1-18
39. McClellan J.M., Werry J.S., and Ham M. A follow-up study of early onset psychosis: comparison between outcome diagnoses of schizophrenia, mood disorders and personality disorders. J. Autism Dev. Disord. 23 (1993) 243-262
40. McClellan J., McCurry C., Speltz J.L., and Jones K. Symptom factors in early-onset psychotic disorders. J. Am. Acad. Child Adolesc. Psych. 41 (2002) 791-798
41. McClellan J., Prezbindowski A., Breiger D., and McCurry C. Neuropsychological functioning in early onset psychotic disorders. Schizophr. Res. 68 (2004) 21-26
42. McKenna K., Gordon C.T., Lenane M., Kaysen D., Fahey K., and Rapoport J.L. Looking for childhood-onset schizophrenia: the first 71 cases screened. J. Am. Acad. Child Adolesc. Psych. 33 (1994) 636-644
43. Menezes N.M., and Milovan E. First-episode psychosis: a comparative review of diagnostic evolution and predictive variables in adolescents versus adults. Can. J. Psychiatry 45 (2000) 710-716
44. Molina V., Reig S., Sanz J., Palomo T., Benito C.S.J., S.J., Sarramea F., Pascau J., and Desco M. Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr. Res. 80 (2005) 61-71
45. Moos R.H., and Moos B.S. Family Environment Manual. 2nd ed. (1986), Consulting Psychologists Press, Palo Alto, CA
46. Moreno D., Burdalo M., Reig S., Parellada M., Zabala A., Desco M., Baca-Baldomero E., and Arango C. Structural neuroimaging in adolescents with a first psychotic episode. J. Am. Acad. Child Psych. 44 (2005) 1151-1157
47. Mukherjee S., Mahadik S.P., Scheffer R., Correnti E.E., and Kelkar H. Impaired antioxidant defense at the onset of psychosis. Schizophr. Res. 19 (1996) 19-26
48. Müller N., Riedel M., Gruber R., Ackenheil M., and Schwarz M.J. The immune system in schizophrenia: An integrative view. Ann. N.Y. Acad. Sci. 917 (2000) 456-467
49. Muntjewerff J.W., Kahn R.S., Blom H.J., and den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol. Psychiatry 11 (2006) 143-149
50. Rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (2006) 429-435
51. Muratori F., Salvadori F., D'Arcangelo G., Viglione V., and Picchi L. Childhood psychopathological antecedents in early onset schizophrenia. Eur. Psychiatr. 20 (2005) 309-314
52. Nicolson R., and Rapoport J.L. Childhood-onset schizophrenia: rare but worth studying. Biol. Psychiatry 46 (1999) 1418-1428
53. Nicolson R., Lenane M., Singaracharlu S., Malaspina D., Giedd J.N., Hamburger S.D., Gochman P., Bedwell J., Thaker G.K., Fernandez T., Wudarsky M., Hommer D.W., and Rapoport J.L. Premorbid speech and language impairments in childhood onset schizophrenia: association with risk factors. Am. J. Psychiatry 157 (2000) 794-800
54. Nicolson R., Brookner F.B., Lenana M., Gochman P., Ingraham L.J., Egan M.F., Kendler K.S., Pickar D., Weinberger D.R., and Rapoport J.L. Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. Am. J. Psychiatry 160 (2003) 490-495
55. Noy S., Achiron A., and Laor N. Schizophrenia and autoimmunity: a possible etiological mechanism?. Neuropsychobiology 30 (1994) 157-159
56. Peralta V., and Cuesta M. Validación de la escala de los sindromes positivo y negativo (PANSS) en una muestra de esquizofrénicos españoles. Actas Luso Esp. Neurol. Psiquiatr. 22 (1994) 171-177
57. Pralong D., Tomaskovic-Crook E., Opeskin K., Copolov D., and Dean B. Serotonin (2A) receptors are reduced in the planum temporale from subjects with schizophrenia. Schizophr. Res. 44 (2000) 35-45
58. Reig S., Pascau J., Penedo M., Arango C., and Desco M. Pooling volumetric data from different scanners: compatibility within and between MR manufacturers. Neuroimage 26 suppl 1 (2005) S44 (Available on CD-ROM)
59. Spencer E.K., and Campbell M. Children with schizophrenia: diagnosis, phenomenology and pharmacotherapy. Schizophr. Bull. 20 (1994) 713-725
60. Staddon S., Arranz M.J., Mancama D., Perez-Nievas F., Arrizabalaga I., Anney R., Buckland P., Elkin A., Osborne S., Munro J., Mata I., and Kerwin R.W. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population. Schizophr. Res. 73 (2005) 49-54
61. Strauss J.S., and Carpenter W.T. The prediction of outcome in schizophrenia: I. Characteristics of outcome. Arch. Gen. Psychiatry 27 (1972) 739-746
62. Talairach J., and Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain (1988), Thieme Medical, New York
63. Thomsen P.H. Schizophrenia with childhood and adolescent onset: a nationwide register-based study. Acta Psychiatr. Scand. 94 (1996) 87-193
64. Ulloa R.E., Ortiz S., Higuera F., Nogales I., Fresan A., Apiquian R., Cortes J., Arechavaleta B., Foulliux C., Martinez P., Hernandez L., Dominguez E., and de la Peña F. Interrater reliability of the Spanish version of the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL). Actas Esp. Psiquiatr. 34 (2006) 36-40
65. Vanhamme L., van den Boogaart A., and Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J. Magn. Reson. 129 (1997) 35-43
66. Volkmar F.R. Childhood and adolescent psychosis: a review of the past 10 years. J. Am. Acad. Child Adolesc. Psych. 30 (1996) 457-465
67. Werry J.S., McClellan J.M., Andrews L.K., and Ham M. Clinical features and outcome of child and adolescent schizophrenia. Schizophr. Bull. 20 (1994) 619-630
68. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978) 429-435
69. Zhang X.Y., Tan Y.L., Cao L.Y., Wu G.Y., Xu Q., Shen Y., and Zhou D.F. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr. Res. 81 (2006) 291-300